Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 7;386(14):1375-1377.
doi: 10.1056/NEJMc2200415. Epub 2022 Feb 9.

Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans

Florian B Mayr  1 , Victor B Talisa  1 , Obaid Shaikh  1 , Sachin Yende  1 , Adeel A Butt  1
Affiliations

Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans

Florian B Mayr et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

References

    1. Centers for Disease Control and Prevention. CDC expands booster shot eligibility and strengthens recommendations for 12-17 year olds. January 5, 2022. (https://www.cdc.gov/media/releases/2022/s0105-Booster-Shot.html).
    1. Atmar RL, Lyke KE, Deming ME, et al. Homologous and heterologous Covid-19 booster vaccinations. N Engl J Med. DOI: 10.1056/NEJMoa2116414. - DOI - PMC - PubMed
    1. Barros-Martins J, Hammerschmidt SI, Cossmann A, et al. Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination. Nat Med 2021;27:1525-1529. - PMC - PubMed
    1. Normark J, Vikström L, Gwon Y-D, et al. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 vaccination. N Engl J Med 2021;385:1049-1051. - PMC - PubMed
    1. Liu X, Shaw RH, Stuart ASV, et al. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet 2021;398:856-869. - PMC - PubMed

Supplementary concepts